DMBT1 as a clinical marker and uses thereof

Details for Australian Patent Application No. 2004277604 (hide)

Owner Janssen Pharmaceutica NV

Inventors Tynan, Sharon Hughes; Pacia, Emmanuel; Allan, George; Guo, JianZhong; Lundeen, Scott

Agent Shelston IP

Pub. Number AU-A-2004277604

PCT Pub. Number WO2005/033661

Priority 60/508,484 03.10.03 US

Filing date 1 October 2004

Wipo publication date 14 April 2005

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/033661 Priority application(s): WO2005/033661

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277605-Insulated panel and glazing system comprising the same

2004277589-Compositions and processes for genotyping single nucleotide polymorphisms